Dermal Filler Market

U.S. Dermal Filler Market Outlook 2031

• The dermal filler market in the U.S. was valued over US$ 1.2 Bn in 2021
• The market in the country is projected to expand at a CAGR of 10.9% from 2022 to 2031
• The dermal filler market in the U.S. is anticipated to reach US$ 3.3 Bn by the end of 2031

Analysts’ Viewpoint on U.S. Dermal Filler Market Scenario

Dermal fillers are injectable implants that are commonly utilized to provide the appearance of a perfect and rejuvenated face. The dermal fillers market growth has been propelled by its use in a variety of applications that help in enhancing an individual's appearance. In the sector of cosmetics, a rising number of firms are heavily spending on research and development (R&D) to create innovative technologies. This has resulted in the development of higher-quality fillers that are easier to use and provide high patient satisfaction. Hyaluronic acid obtained from non-animal sources has been used as a dermal filler for a long time and demonstrated to be safe and effective. Some of the industry's biggest players have been launching new formulations that will help the dermal filler market to grow.

Overview of U.S. Dermal Filler Market

The dermal filler market in the U.S. is driven by rising acceptance of anti-aging treatment by elderly individuals globally. Dermal fillers can be defined as soft tissue fillers injected into the skin for the restoration of smoother appearance and reduction of wrinkles and signs of aging. Regions with low cost of dermal filler procedures has witnessed a surge in the demand for these procedures. Countries such as India, Brazil, and Dubai report significant number of patients from the U.S. and countries in Europe coming in for dermal filler procedures.

Celebrity endorsement is a powerful and useful tool that magnifies the effect of a campaign. Hence, several key players use the celebrity endorsement strategy for marketing their products. This strategy is projected to strengthen the image of their brands in the digital world and attract new customers.

Increase in penetration of Internet in the developed and the developing regions provides consumers an opportunity to research on various dermal filler procedures available for the treatment of skin and facial ailments, and which aids in the growth of online sales. Various types of dermal fillers are used in the dermal filler procedures for the different purpose such as soft tissue fillers used for smoothing skin and lessening the prominence of wrinkles, and face fillers used to improve the appearance of facial lines.

Facial fillers are substances injected into the skin to smooth wrinkles and make them less noticeable. Additionally, the advantage of product comparison, rise in demand for maintaining youthful features, and rise in fad of anti-aging, owing to a surge in social media awareness contribute to the growth of the market in the U.S.

Request a sample to get extensive insights into the Dermal Filler Market

Rise in Preference for Minimally Invasive Procedures to Boost U.S. Dermal Filler Market

The demand for non-surgical dermatological procedures has increased significantly, due to several advantages offered by these methods. These include faster results, cost-effectiveness, and fewer associated risks than conventional methods. Moreover, increase in focus of people on facial correction and rise in desire to look young drive the demand for non-invasive dermatological procedures.

In minimally invasive procedures injectable dermal fillers are used to plump thin lips, enhance shallow contours, soften facial creases, remove wrinkles and improve the appearance of scars.

An estimated 1.4 million surgical and non-surgical treatments were performed in 2021, with plastic surgeons doing 600 more operations on average than they did in 2020.

Moreover, according to the American Society of Plastic Surgeons, 2.7 million facial filler procedures were performed in 2017.

Hence, rise in preference for minimally invasive procedures is expected to propel the market in the U.S. during the forecast period.

Increase in Number of People Undergoing Lip Enhancement Procedures to Augment U.S. Market

Lip enhancement is likely to be the fastest growing segment of the market in the U.S. in terms of CAGR by 2031. The segment is anticipated to reach 10.7% by 2031. The demand for lip enhancement has increased rapidly, owing to the rising fad of the selfie culture. The market for lip enhancement has been booming due to an increasing number of young population preferring to modify their lips for a plump and voluminous appearance. According to the American Society of Plastic Surgeons (ASPS), dermal fillers is a common procedure employed for lip augmentation in over 85% of patients. Moreover, this trend has been gaining popularity among the male population as well, leading to a significant rise in the number of men undergoing lip enhancements. For instance, the recent statistics from the American Society of Plastic Surgeons reveal that 27,000 lip augmentation procedures were performed last year (2020). To put that number in context, a lip augmentation procedure was performed nearly every 20 minutes.

Thus, rise in preference for lip enhancement in both men and women, and extensive usage of dermal fillers for performing these procedures are expected to propel the market in the U.S.

Non-toxicity and Prolonged Shelf Life Drive Demand for Biodegradable Materials

In terms of product, the dermal filler market in the U.S. has been bifurcated into biodegradable and non-biodegradable. The biodegradable segment led the dermal filler market in the U.S. in 2021. The segment is anticipated to account for major share of the market by 2031. The biodegradable segment is expected to expand at a CAGR of 11.0% from 2022 to 2031.

The benefits of biodegradable materials, such as polylactic acid, as non-toxicity and prolonged material shelf life, contribute to the high segmental value. As a result, increased procedural volume and product benefits are likely to propel the biodegradable dermal filler market during the forecast period.

Hyaluronic Acid-based Dermal Fillers Assure Less Severe Effects, Offer Several Other Benefits

The hyaluronic acid segment held key share of the market in the U.S. in terms of revenue in 2021, and the trend is likely to continue during the forecast period. This can be attributed to the growing concern among both men and women about preserving beauty standards. People are opting for therapy to smooth the skin texture or repair wrinkles, augment lips, and other cosmetic treatments to improve physical appearance due to ever-changing beauty standards. Tear trough fillers use hyaluronic acid to plump, firm and fill the hollows under the eyes to give a fresher, brighter appearance.

The assurance of less adverse effects from these treatment procedures has boosted the demand for hyaluronic acid based dermal fillers. This, combined with increase in demand for aesthetics and rise in awareness about hyaluronic acid-based dermal fillers such as tear trough fillers propel the market in the region.

High Demand for Dermal Fillers from Dermatology Clinics in U.S.

In terms of end-user, the dermal filler market in the U.S. has been divided into hospitals, dermatology clinics, aesthetics centers, and others. The dermatology clinics segment led the dermal filler market in the country in 2021. The segment is anticipated to account for major market share in the U.S. by 2031. The clinics segment is expected to expand at a high CAGR rate from 2022 to 2031. According to IMS Health, the U.S. has an estimated 9,600 dermatologists and 7,800 dermatology practices.

Competitive Landscape

The dermal filler market in the U.S. is fragmented due to the presence of a large number of players. Key players operating in the market in the country include AbbVie, Advanced Aesthetic Technologies, Anika Therapeutics, Inc., BioPlus Co., Ltd., Croma-Pharma GmbH, Cytophil, Inc., DR. Korman Laboratories, Galderma, Huons USA, Merz Pharma GmbH & Co. KGaA, Revance, Sinclair Pharma, Suneva Medical, Inc., Syneron Medical Ltd., and TEOXANE Laboratories.

Each of these players has been profiled in the dermal filler market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

The key players are adopting growth strategies such as new product development, product launches, product approval, agreement, partnerships, and mergers.

For instance, Restylane filler is an FDA-approved dermal filler made primarily with hyaluronic acid. Restylane Lyft is the first FDA-approved hyaluronic acid filler used for the face and the back of the hands.

Request a custom report on Dermal Filler Market

Key Developments in U.S. Dermal Filler Market

• For instance, in November 2021, Galderma announced that it has signed a definitive agreement to acquire ALASTIN Skincare, Inc., a specialty aesthetics company dedicated to developing innovative and clinically-tested physician-dispensed skincare products. The acquisition is subject to customary closing conditions and necessary regulatory approvals.
• In October 2020, AbbVie announced that it has entered into an agreement with Luminera, a privately held aesthetics company based in Israel with a portfolio and pipeline of dermal filler products. Under the terms of the agreement, Allergan Aesthetics acquired Luminera's full dermal filler portfolio and R&D pipeline, further enhancing Allergan Aesthetics' leading dermal filler portfolio with its JUVÉDERM collection of fillers.
• In May 2020, Restylane received approval from the USFDA for Restylane Kysse. It’s a lip filler designed to improve the lips’ volume, texture, and even color. Restylane Kysse lasts for one year and is in high demand for lip enhancement

U.S. Dermal Filler Market Snapshot